Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.

Jonggi ChoiDanbi LeeJu Hyun ShimKang Mo KimYoung Suk LimYung Sang LeeHan Chu Lee

Published in: PloS one (2020)

Patients showing no OR to two consecutive TACE sessions will present a poor OR to subsequent TACE procedures. Early transition to systemic therapy may be advocated in such cases.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
radiofrequency ablation
mesenchymal stem cells
bone marrow